MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

Search

Alcon Inc

Open

BrancheGesundheitswesen

81.85 0.5

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

80.88

Max

82.12

Schlüsselkennzahlen

By Trading Economics

Einkommen

55M

238M

Verkäufe

18M

2.6B

KGV

Branchendurchschnitt

37.619

89.037

Dividendenrendite

0.42

Gewinnspanne

9.11

Angestellte

25,000

EBITDA

415M

665M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+15.72% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.42%

2.18%

Nächstes Ergebnis

24. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

2.2B

39B

Vorheriger Eröffnungskurs

81.35

Vorheriger Schlusskurs

81.85

Nachrichtenstimmung

By Acuity

25%

75%

66 / 360 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Alcon Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

6. Jan. 2026, 15:11 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9. Dez. 2025, 18:51 UTC

Akquisitionen, Fusionen, Übernahmen

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9. Dez. 2025, 15:54 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9. Dez. 2025, 14:32 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon Upgrades Offer Price for Staar Surgical

12. Nov. 2025, 09:09 UTC

Ergebnisse
Wichtige Markttreiber

Alcon Shares in Switzerland Climb After Guidance Confirmation

7. Jan. 2026, 01:00 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6. Jan. 2026, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6. Jan. 2026, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6. Jan. 2026, 15:21 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6. Jan. 2026, 14:56 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6. Jan. 2026, 14:14 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6. Jan. 2026, 14:14 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6. Jan. 2026, 14:14 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6. Jan. 2026, 14:13 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9. Dez. 2025, 14:17 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon Ups Offer Price for Staar Surgical

9. Dez. 2025, 13:34 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9. Dez. 2025, 13:33 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9. Dez. 2025, 13:33 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9. Dez. 2025, 13:33 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9. Dez. 2025, 13:32 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9. Dez. 2025, 13:32 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

9. Dez. 2025, 13:31 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC

9. Dez. 2025, 13:31 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon Announces Amended Merger Agreement With STAAR Surgical

9. Dez. 2025, 13:31 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon Enters Amended Merger Agreement for Acquisition of STAAR Surgical >ALC

12. Nov. 2025, 08:46 UTC

Market Talk

Alcon's Guidance Reiteration Offers Relief -- Market Talk

11. Nov. 2025, 21:35 UTC

Ergebnisse

Alcon 3Q Adj EPS 79c >ALC

11. Nov. 2025, 21:35 UTC

Ergebnisse

Alcon 3Q Rev $2.61B >ALC.EB

11. Nov. 2025, 21:35 UTC

Ergebnisse

Alcon Backs 2025 EPS $3.05-EPS $3.15 >ALC.EB

11. Nov. 2025, 21:35 UTC

Ergebnisse

Alcon 3Q EPS 48c >ALC.EB

11. Nov. 2025, 21:34 UTC

Ergebnisse

Alcon Backs 2025 Adj EPS $3.05-Adj EPS $3.15 >ALC

Peer-Vergleich

Kursveränderung

Alcon Inc Prognose

Kursziel

By TipRanks

15.72% Vorteil

12-Monats-Prognose

Durchschnitt 91.49 USD  15.72%

Hoch 112.534 USD

Tief 75.023 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Alcon Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

12 ratings

7

Buy

4

Halten

1

Sell

Technischer Score

By Trading Central

95.77 / 97.61Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Strong Bullish Evidence

Stimmung

By Acuity

66 / 360 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat